Jane Street Group LLC purchased a new stake in Steris PLC (NYSE:STE) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 7,445 shares of the medical equipment provider’s stock, valued at approximately $782,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Great West Life Assurance Co. Can boosted its stake in shares of Steris by 0.5% in the 2nd quarter. Great West Life Assurance Co. Can now owns 137,263 shares of the medical equipment provider’s stock valued at $14,452,000 after purchasing an additional 697 shares during the last quarter. Segall Bryant & Hamill LLC bought a new stake in shares of Steris in the 2nd quarter valued at $557,000. Oregon Public Employees Retirement Fund boosted its stake in shares of Steris by 3.0% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 33,019 shares of the medical equipment provider’s stock valued at $3,467,000 after purchasing an additional 953 shares during the last quarter. Aperio Group LLC boosted its stake in shares of Steris by 20.0% in the 2nd quarter. Aperio Group LLC now owns 22,844 shares of the medical equipment provider’s stock valued at $2,399,000 after purchasing an additional 3,814 shares during the last quarter. Finally, Strs Ohio bought a new stake in shares of Steris in the 2nd quarter valued at $612,000. Hedge funds and other institutional investors own 88.77% of the company’s stock.
STE has been the topic of a number of analyst reports. Zacks Investment Research raised shares of Steris from a “sell” rating to a “hold” rating in a research note on Thursday, September 20th. JMP Securities upped their price objective on shares of Steris from $113.00 to $125.00 and gave the company a “market outperform” rating in a research note on Thursday, August 9th. Stephens reaffirmed a “buy” rating and issued a $125.00 price objective on shares of Steris in a research note on Thursday, August 9th. Finally, KeyCorp upped their price objective on shares of Steris from $115.00 to $120.00 and gave the company an “overweight” rating in a research note on Thursday, August 9th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $100.86.
In related news, VP Karen L. Burton sold 1,300 shares of the stock in a transaction on Tuesday, August 14th. The shares were sold at an average price of $114.39, for a total transaction of $148,707.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the stock in a transaction on Friday, July 13th. The stock was sold at an average price of $110.50, for a total transaction of $1,105,000.00. The disclosure for this sale can be found here. 2.38% of the stock is owned by corporate insiders.
Shares of NYSE STE opened at $107.71 on Tuesday. The firm has a market cap of $9.67 billion, a P/E ratio of 26.26 and a beta of 1.06. Steris PLC has a 12-month low of $82.88 and a 12-month high of $117.48. The company has a debt-to-equity ratio of 0.43, a quick ratio of 2.02 and a current ratio of 2.65.
Steris (NYSE:STE) last issued its earnings results on Wednesday, August 8th. The medical equipment provider reported $1.00 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.99 by $0.01. The business had revenue of $638.76 million for the quarter, compared to analyst estimates of $638.63 million. Steris had a net margin of 11.42% and a return on equity of 11.80%. Steris’s revenue was up 5.1% on a year-over-year basis. During the same period in the prior year, the firm earned $0.85 earnings per share. Equities research analysts predict that Steris PLC will post 4.71 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Thursday, September 27th. Investors of record on Wednesday, August 29th were paid a dividend of $0.34 per share. The ex-dividend date of this dividend was Tuesday, August 28th. This is a positive change from Steris’s previous quarterly dividend of $0.31. This represents a $1.36 annualized dividend and a yield of 1.26%. Steris’s dividend payout ratio is currently 32.77%.
Steris Company Profile
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Read More: How Do I Invest in Dividend Stocks
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.